在乳腺癌中具有抗癌活性的修饰性pectin:一个系统性审查
Gabino Garrido1, Bárbara B Garrido-Suárez2, Mario Mieres-Arancibia1
1Departamento de Ciencias Farmacéuticas, Universidad Católica del Norte, Angamos 0610, Antofagasta, Chile.
根据一项系统性审查,修改后的pectins (MPs) 显示出对乳腺癌有前途的抗癌活性. 需要进一步的体内研究来证实乳腺癌治疗中的这些积极的临床前发现.
科学领域:
- 瘤学和生物化学
- 探索用于癌症治疗的天然化合物.
背景情况:
- 乳腺癌是全球领先的女性癌症诊断.
- 目前的乳腺癌治疗方法具有显著的副作用和可变的疗效.
- 改性pectins (MPs) 正在成为潜在的抗癌药物.
结论:
- 改性pectins在治疗乳腺癌方面显示出显著的潜力.
- 在细胞系和动物模型中观察到积极的结果.
- 进一步的体内研究至关重要,以确定乳腺癌治疗中改性pectins的确的临床前证据.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Cancer Prevention
Some...
Drugs that Stabilize Microtubules
Cellulose and Pectic Polysaccharides
As a cell matures, its cell wall specializes according to its type. For example, the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Destabilize Microtubules
Inhibition of Cdk Activity
